APA (7th ed.) Citation

R, S., L, T., M, I., WR, W., CA, B., J, H., . . . JRS, D. (2021). Safe and persistent growth-promoting effects of vosoritide in children with achondroplasia: 2-year results from an open-label, phase 3 extension study. Genetics in medicine : official journal of the American College of Medical Genetics, 23(12), 2443. https://doi.org/10.1038/s41436-021-01287-7

Chicago Style (17th ed.) Citation

R, Savarirayan, et al. "Safe and Persistent Growth-promoting Effects of Vosoritide in Children with Achondroplasia: 2-year Results from an Open-label, Phase 3 Extension Study." Genetics in Medicine : Official Journal of the American College of Medical Genetics 23, no. 12 (2021): 2443. https://doi.org/10.1038/s41436-021-01287-7.

MLA (9th ed.) Citation

R, Savarirayan, et al. "Safe and Persistent Growth-promoting Effects of Vosoritide in Children with Achondroplasia: 2-year Results from an Open-label, Phase 3 Extension Study." Genetics in Medicine : Official Journal of the American College of Medical Genetics, vol. 23, no. 12, 2021, p. 2443, https://doi.org/10.1038/s41436-021-01287-7.